Original Source(s)
Related Content
Urine Bladder Cancer Test Could Triage Cystoscopy
Real-world UK study suggests molecular testing could help prioritize patients with hematuria for urgent bladder investigation
September 11, 2026
-
2 min
FDA approves combo for ESR1-mutated breast cancer
In an exploratory subgroup analysis of patients with ESR1-mutated tumors, median progression-free survival was 11.1 months with the combination and 5.5 months with imlunestrant alone.
September 21, 2026
-
2 min
Mild metabolic profile may mask MASLD risk
Five reproducible MASLD subtypes showed distinct genetic profiles and patterns of metabolic comorbidity and disease progression.
September 10, 2026
-
4 min
